Access the full text.
Sign up today, get DeepDyve free for 14 days.
G. Paxinos, Charles Watson (1983)
The Rat Brain in Stereotaxic Coordinates
(1983)
Stress and drugs
L. Gonzalez, A. Ouagazzal, S. File (1998)
Stimulation of benzodiazepine receptors in the dorsal hippocampus and median raphé reveals differential GABAergic control in two animal tests of anxietyEuropean Journal of Neuroscience, 10
J. Brioni, A. O'Neill, David Kim, M. Buckley, M. Decker, S. Arneric (1994)
Anxiolytic-like effects of the novel cholinergic channel activator ABT-418.The Journal of pharmacology and experimental therapeutics, 271 1
L. Gonzalez, S. File (1997)
A Five Minute Experience in the Elevated Plus-Maze Alters the State of the Benzodiazepine Receptor in the Dorsal Raphe NucleusThe Journal of Neuroscience, 17
A. Vale, S. Green (1996)
Effects of chlordiazepoxide, nicotine and d‐amphetamine in the rat potentiated startle model of anxietyBehavioural Pharmacology, 7
P. Mora, C. Netto, F. Graeff (1997)
Role of 5-HT2A and 5-HT2C Receptor Subtypes in the Two Types of Fear Generated by the Elevated T-MazePharmacology Biochemistry and Behavior, 58
D. Chalmers, T. Lovenberg, D. Grigoriadis, D. Behan, E. Souza (1996)
Corticotrophin-releasing factor receptors: from molecular biology to drug design.Trends in pharmacological sciences, 17 4
J. Herman, W. Cullinan (1997)
Neurocircuitry of stress: central control of the hypothalamo–pituitary–adrenocortical axisTrends in Neurosciences, 20
R. Rodgers (1997)
Animal models of 'anxiety': where next?Behavioural pharmacology, 8 6-7
B. Sharp, S. Matta (1993)
Detection by in vivo microdialysis of nicotine-induced norepinephrine secretion from the hypothalamic paraventricular nucleus of freely moving rats: dose-dependency and desensitization.Endocrinology, 133 1
D. Balfour, M. Benwell, C. Graham, A. Vale (1986)
Behavioural and adrenocortical responses to nicotine measured in rats with selective lesions of the 5‐hydroxytryptaminergic fibres innervating the hippocampusBritish Journal of Pharmacology, 89
S. File, L. Gonzalez, N. Andrews (1998)
Endogenous acetylcholine in the dorsal hippocampus reduces anxiety through actions on nicotinic and muscarinic1 receptors.Behavioral neuroscience, 112 2
T. Onaka, J. Palmer, K. Yagi (1996)
Norepinephrine depletion impairs neuroendocrine responses to fear but not novel environmental stimuli in the ratBrain Research, 713
W. Cao, Trent Burkholder, Lincoln Wilkins, A. Collins (1993)
A genetic comparison of behavioral actions of ethanol and nicotine in the mirrored chamberPharmacology Biochemistry and Behavior, 45
S. File, N. Andrews, P. Wu, A. Zharkovsky, H. Zangrossi (1992)
Modification of chlordiazepoxide's behavioural and neurochemical effects by handling and plus-maze experience.European journal of pharmacology, 218 1
Rafael Salín-Pascual, M. Rosas, A. Jimenez-Genchi, Rivera-Meza Bl, Delgado-Parra (1996)
Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major depression.The Journal of clinical psychiatry, 57 9
Anxiolytic and an - xiogenic effects of nicotine in the social interaction test : role of dorsal hippocampus
C. Fernandes, S. File (1996)
The influence of open arm ledges and maze experience in the elevated plus-mazePharmacology Biochemistry and Behavior, 54
J. Day, M. Koehl, V. Deroche, M. Moal, S. Maccari (1998)
Prenatal Stress Enhances Stress- and Corticotropin-Releasing Factor-Induced Stimulation of Hippocampal Acetylcholine Release in Adult RatsThe Journal of Neuroscience, 18
M. Brazell, S. Mitchell, J. Gray (1991)
Effect of acute administration of nicotine on in vivo release of noradrenaline in the hippocampus of freely moving rats: A dose-response and antagonist studyNeuropharmacology, 30
S. File, S. Vellucci (1978)
Studies on the role of ACTH and of 5‐HT in anxiety, using an animal modelJournal of Pharmacy and Pharmacology, 30
M. Jessa, M. Nazar, A. Płażnik (1995)
Anxiolytic-like action of intra-hippocampally administered NMDA antagonists in rats.Polish journal of pharmacology, 47 1
R. Rodgers, N. Johnson, J. Cole, C. Dewar, G. Kidd, P. Kimpson (1996)
Plus-maze retest profile in mice: Importance of initial stages of trial 1 and response to post-trial cholinergic receptor blockadePharmacology Biochemistry and Behavior, 54
L. Seyler, O. Pomerleau, J. Fertig, Dorothy Hunt, K. Parker (1986)
Pituitary hormone response to cigarette smokingPharmacology Biochemistry and Behavior, 24
D. Treit, J. Menard (1997)
Dissociations among the anxiolytic effects of septal, hippocampal, and amygdaloid lesions.Behavioral neuroscience, 111 3
S. Matta, K. Mcallen, B. Sharp (1990)
Role of the fourth cerebroventricle in mediating rat plasma ACTH responses to intravenous nicotine.The Journal of pharmacology and experimental therapeutics, 252 2
B. Costall, M. Kelly, R. Naylor, E. Onaivi (1989)
The actions of nicotine and cocaine in a mouse model of anxietyPharmacology Biochemistry and Behavior, 33
A. Dunn, S. File (1987)
Corticotropin-releasing factor has an anxiogenic action in the social interaction testHormones and Behavior, 21
D. Helton, J. Tizzano, J. Monn, D. Schoepp, M. Kallman (1998)
Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors.The Journal of pharmacology and experimental therapeutics, 284 2
J. Bremner, J. Krystal, S. Southwick, D. Charney (1996)
Noradrenergic mechanisms in stress and anxiety: I. preclinical studiesSynapse, 23
C. Hess, D. Blozovski (1987)
Hippocampal muscarinic cholinergic mediation of spontaneous alternation and fear in the developing ratBehavioural Brain Research, 24
Hippocampal and septal nicotinic modulation of anxiety reveals differences among animal tests
Y. Fu, S. Matta, T. James, B. Sharp (1998)
Nicotine-induced norepinephrine release in the rat amygdala and hippocampus is mediated through brainstem nicotinic cholinergic receptors.The Journal of pharmacology and experimental therapeutics, 284 3
S. File (1993)
The interplay of learning and anxiety in the elevated plus-mazeBehavioural Brain Research, 58
(1992)
Behavioural detection of anxiolytic action
S. Pellow, P. Chopin, S. File, M. Briley (1985)
Validation of open : closed arm entries in an elevated plus-maze as a measure of anxiety in the ratJournal of Neuroscience Methods, 14
S. File, L. Gonzalez, N. Andrews (1996)
Comparative Study of Pre- and Postsynaptic 5-HT1AReceptor Modulation of Anxiety in Two Ethological Animal TestsThe Journal of Neuroscience, 16
A. Aloisi, F. Casamenti, C. Scali, G. Pepeu, G. Carli (1997)
Effects of novelty, pain and stress on hippocampal extracellular acetylcholine levels in male ratsBrain Research, 748
H. Okuda, S. Shioda, Y. Nakai, H. Nakayama, M. Okamoto, T. Nakashima (1993)
The presence of corticotropin-releasing factor-like immunoreactive synaptic vesicles in axon terminals with nicotinic acetylcholine receptor-like immunoreactivity in the median eminence of the ratNeuroscience Letters, 161
F. Graeff, M. Viana, P. Mora (1996)
Opposed regulation by dorsal raphe nucleus 5-HT pathways of two types of fear in the elevated T-mazePharmacology Biochemistry and Behavior, 53
A. Collins, L. Miner, M. Marks (1988)
Genetic influences on acute responses to nicotine and nicotine tolerance in the mousePharmacology Biochemistry and Behavior, 30
R. Salín-Pascual, R. Drucker-Colín (1998)
A novel effect of nicotine on mood and sleep in major depressionNeuroReport, 9
J. Smythe, S. Bhatnagar, D. Murphy, C. Timothy, B. Costall (1998)
The Effects of Intrahippocampal Scopolamine Infusions on Anxiety in Rats as Measured by the Black–White Box TestBrain Research Bulletin, 45
N. Breslau, M. Kilbey, P. Andreski (1991)
Nicotine dependence, major depression, and anxiety in young adults.Archives of general psychiatry, 48 12
J. Brioni, M. Decker, J. Sullivan, S. Arneric (1997)
The pharmacology of (-)-nicotine and novel cholinergic channel modulators.Advances in pharmacology, 37
J. Gray, S. Mitchell, M. Joseph, G. Grigoryan, S. Dawe, H. Hodges (1994)
Neurochemical mechanisms mediating the behavioral and cognitive effects of nicotineDrug Development Research, 31
Rationale: The elevated plus-maze provides a test situation in which distinctive states of anxiety are elicited on trials 1 and 2 and the dorsal hippocampus has previously been shown to mediate the anxiogenic effects of (–)-nicotine in the social interaction test. Objective: To determine the effects of a wide dose range of (–)-nicotine on trial 1 and 2 in the plus-maze after systemic administration and whether the dorsal hippocampus is a site mediating the anxiogenic effect of nicotine. Methods: (–)-Nicotine (0.001, 0.005, 0.01, 0.05, 0.1, 0.5 and 1 mg/kg) was injected IP 30 min before testing for 5 min in the plus-maze. Rats receiving dorsal hippocampal infusions received bilateral infusions of 0.5 μl of artificial CSF or (–)-nicotine (0.1, 1, 4 or 8 μg). The needle was left in place for 50 s after injection and testing took place 3 min later. Rats tested on trial 1 were naive to the plus-maze, those tested on trial 2 had received a previous 5-min undrugged exposure to the maze 48 h earlier. Results: Low doses of (–)-nicotine (0.001, 0.005, 0.01, 0.05 and 0.1 mg/kg, IP) were without effect on either trial, but higher doses (0.5 and 1 mg/kg, IP) had anxiogenic effects on both trials, as shown by decreases in percentage time spent and percentage entries onto the open arms. Infusion of (–)-nicotine (0.1, 1, 4 and 8 μg) bilaterally into the dorsal hippocampus was without effect on trial 1, but 1 μg had an anxiolytic effect on trial 2, shown by an increased percentage time spent on the open arms. Conclusions: The results on both trials in the plus-maze after systemic administration of nicotine add to previous reports from the social interaction test that high doses of nicotine have anxiogenic effects. However, the effects of nicotine in the dorsal hippocampus are different in all three anxiety tests (anxiogenic in social interaction, ineffective on trial 1, anxiolytic on trial 2) showing that nicotinic cholinergic control in this brain region may vary depending on the state and/or type of anxiety generated by the test. The brain region(s) underlying the anxiogenic effects of IP nicotine on both trials in the plus-maze remain to be identified.
Psychopharmacology – Springer Journals
Published: May 1, 1999
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.